xiaoniu2021的个人主页 - 老虎社区

xiaoniu2021

xiaoniu2021

暂无个人介绍

IP属地：未知

73关注

1粉丝

0主题

0勋章

2021-06-08

Please like and comment for me

抱歉，原内容已删除

2021-06-14

Pls comment and like with many thanks

抱歉，原内容已删除

2021-06-22

Nice

抱歉，原内容已删除

2021-06-12

Cool

抱歉，原内容已删除

2021-06-07

Yea

抱歉，原内容已删除

2021-06-22

Like and comment. Thank you

抱歉，原内容已删除

2021-06-17

Like and comment pls. Thanks 😊

抱歉，原内容已删除

2021-06-08

Nice

Opinion: Only ‘greedy’ drug companies will cure Alzheimer’s<blockquote>观点：只有“贪婪”的制药公司才能治愈阿尔茨海默病</blockquote>

2021-06-07

Hmm

抱歉，原内容已删除

2021-06-07

Good

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3582279635767115","uuid":"3582279635767115","gmtCreate":1619187349090,"gmtModify":1622772964080,"name":"xiaoniu2021","pinyin":"xiaoniu2021","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":73,"tweetSize":25,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.01%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":144127981,"gmtCreate":1626272599843,"gmtModify":1631893946598,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Good night bro","listText":"Good night bro","text":"Good night bro","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/144127981","repostId":"144126462","repostType":1,"repost":{"id":144126462,"gmtCreate":1626272507556,"gmtModify":1633928396670,"author":{"id":"3571397064539484","authorId":"3571397064539484","name":"Heibi","avatar":"https://static.tigerbbs.com/a4b0cb7e69d4c38018b1a3a840f08834","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3571397064539484","idStr":"3571397064539484"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Time to sleep lol gd night all 💎👐","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Time to sleep lol gd night all 💎👐","text":"$AMC Entertainment(AMC)$Time to sleep lol gd night all 💎👐","images":[{"img":"https://static.tigerbbs.com/5f51c54dc6d43d9c611bbc07ccb85dbf","width":"1284","height":"2457"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/144126462","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":757,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125407689,"gmtCreate":1624683557641,"gmtModify":1631893946601,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/125407689","repostId":"1108941456","repostType":4,"isVote":1,"tweetType":1,"viewCount":742,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128641808,"gmtCreate":1624515467904,"gmtModify":1631893946604,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Like.and comments pls","listText":"Like.and comments pls","text":"Like.and comments pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/128641808","repostId":"2145012425","repostType":4,"isVote":1,"tweetType":1,"viewCount":829,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129947356,"gmtCreate":1624354790375,"gmtModify":1631893946605,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Like and comment.&nbsp; Thank you","listText":"Like and comment.&nbsp; Thank you","text":"Like and comment. Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/129947356","repostId":"1186919064","repostType":4,"isVote":1,"tweetType":1,"viewCount":1063,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120825133,"gmtCreate":1624319468622,"gmtModify":1631893946608,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/120825133","repostId":"1167650307","repostType":4,"isVote":1,"tweetType":1,"viewCount":1482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120330009,"gmtCreate":1624296497101,"gmtModify":1631883985890,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"The market pulled back after the latest Fed meeting on Wednesday, where policymakers signaled they expect to raise interest rates by late 2023, sooner than they had previously anticipated. The selloff intensified Friday after St. Louis Fed President James Bullard told CNBC he sees the Fed starting to raise interest rates in late 2022.Now is a time to be looking to add stocks to one's watchlist, but why do the stocks chosen above stand out? Before turning to that question, it is important to consider how one goes about choosing a stock in the first place. Superior fundamentals and technical action, and buying at the right time, are all part of a shrewd investing formula.","listText":"The market pulled back after the latest Fed meeting on Wednesday, where policymakers signaled they expect to raise interest rates by late 2023, sooner than they had previously anticipated. The selloff intensified Friday after St. Louis Fed President James Bullard told CNBC he sees the Fed starting to raise interest rates in late 2022.Now is a time to be looking to add stocks to one's watchlist, but why do the stocks chosen above stand out? Before turning to that question, it is important to consider how one goes about choosing a stock in the first place. Superior fundamentals and technical action, and buying at the right time, are all part of a shrewd investing formula.","text":"The market pulled back after the latest Fed meeting on Wednesday, where policymakers signaled they expect to raise interest rates by late 2023, sooner than they had previously anticipated. The selloff intensified Friday after St. Louis Fed President James Bullard told CNBC he sees the Fed starting to raise interest rates in late 2022.Now is a time to be looking to add stocks to one's watchlist, but why do the stocks chosen above stand out? Before turning to that question, it is important to consider how one goes about choosing a stock in the first place. Superior fundamentals and technical action, and buying at the right time, are all part of a shrewd investing formula.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/120330009","repostId":"2145084835","repostType":4,"isVote":1,"tweetType":1,"viewCount":1145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162305518,"gmtCreate":1624033327334,"gmtModify":1631893946610,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Good say. Oil is back","listText":"Good say. Oil is back","text":"Good say. Oil is back","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/162305518","repostId":"1138062216","repostType":4,"isVote":1,"tweetType":1,"viewCount":873,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166895084,"gmtCreate":1624000341948,"gmtModify":1631893946614,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Pls like and comment.&nbsp; Thanks","listText":"Pls like and comment.&nbsp; Thanks","text":"Pls like and comment. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166895084","repostId":"1149669763","repostType":4,"isVote":1,"tweetType":1,"viewCount":1186,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161037621,"gmtCreate":1623896069063,"gmtModify":1631893946617,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Like and comment pls. Thanks 😊","listText":"Like and comment pls. Thanks 😊","text":"Like and comment pls. Thanks 😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/161037621","repostId":"2144130887","repostType":4,"isVote":1,"tweetType":1,"viewCount":1314,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185221565,"gmtCreate":1623654921057,"gmtModify":1631893946625,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Pls comment and like with many thanks","listText":"Pls comment and like with many thanks","text":"Pls comment and like with many thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/185221565","repostId":"1146430910","repostType":4,"isVote":1,"tweetType":1,"viewCount":1454,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185221809,"gmtCreate":1623654870901,"gmtModify":1631893946628,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/185221809","repostId":"1165811803","repostType":4,"isVote":1,"tweetType":1,"viewCount":500,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188293635,"gmtCreate":1623441824927,"gmtModify":1634033168950,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/188293635","repostId":"2142572209","repostType":4,"isVote":1,"tweetType":1,"viewCount":412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183267572,"gmtCreate":1623333288296,"gmtModify":1634034477873,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Zhun bo","listText":"Zhun bo","text":"Zhun bo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/183267572","repostId":"1128810191","repostType":4,"isVote":1,"tweetType":1,"viewCount":324,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180098584,"gmtCreate":1623163289348,"gmtModify":1634036257334,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Sad case for me&nbsp;","listText":"Sad case for me&nbsp;","text":"Sad case for me","images":[{"img":"https://static.tigerbbs.com/ddfa3fdd2e235373a5b97424619bef67","width":"1080","height":"2679"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/180098584","isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":117542129,"gmtCreate":1623154023161,"gmtModify":1634036405390,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Please like and comment for me","listText":"Please like and comment for me","text":"Please like and comment for me","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/117542129","repostId":"1154765176","repostType":4,"isVote":1,"tweetType":1,"viewCount":602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117546144,"gmtCreate":1623153945988,"gmtModify":1634036405977,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Yeah!!","listText":"Yeah!!","text":"Yeah!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/117546144","repostId":"1111940861","repostType":4,"isVote":1,"tweetType":1,"viewCount":582,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117543634,"gmtCreate":1623153771328,"gmtModify":1634036407976,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/117543634","repostId":"1127979401","repostType":4,"repost":{"id":"1127979401","kind":"news","pubTimestamp":1623153568,"share":"https://www.laohu8.com/m/news/1127979401?lang=zh_CN&edition=full","pubTime":"2021-06-08 19:59","market":"us","language":"en","title":"Opinion: Only ‘greedy’ drug companies will cure Alzheimer’s<blockquote>观点：只有“贪婪”的制药公司才能治愈阿尔茨海默病</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1127979401","media":"marketwatch","summary":"Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my ","content":"<p><img src=\"https://static.tigerbbs.com/783580e857537ceb68ca7c6330ee4132\" tg-width=\"1260\" tg-height=\"736\">Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my fellow members of the (ahem) “mainstream media.”</p><p><blockquote>这里有一个问题要问国会和白宫的每个人，联邦官僚机构，以及我所有的（咳咳）“主流媒体”的同事们。</blockquote></p><p> Now that BiogenBIIB,+38.34%has got approval forits new Alzheimer’s drug—the first approved by the FDA in almost 20 years — how much should they be allowed to charge for it?</p><p><blockquote>既然BiogenBIIB，+38.34%的新药已经获得批准——这是近20年来FDA批准的第一种药物——他们应该被允许收取多少费用？</blockquote></p><p> What’s the ethically correct figure? What will exempt them from charges of “greed” or “gouging?” What is “too much?”</p><p><blockquote>伦理上正确的数字是多少？什么能免除他们“贪婪”或“欺诈”的指控？什么是“太多了？”</blockquote></p><p> The manufacturing cost per pill? The cost plus a small margin? What’s the number?</p><p><blockquote>每粒药丸的制造成本？成本加上一点利润？号码是多少？</blockquote></p><p> I bring this up because few things matter as much for the lives of senior citizens in America—and seniors in the rest of the world—than the development of new drugs. I have personally seen up close how Alzheimer’s destroys people, sometimes as young as their 50s and 60s. This has included close members of my family.</p><p><blockquote>我提出这个问题是因为对于美国老年人——以及世界其他地方的老年人——的生活来说，没有什么比新药的开发更重要的了。我亲眼目睹了老年痴呆症是如何摧毁人的，有时只有五六十岁的人。这包括我的近亲。</blockquote></p><p> Some six million Americans already have this cruel, vicious and incurable disease, and ahorrific 50 million around the world. That’s 50 million death sentences. Ten million more get it every year.</p><p><blockquote>大约600万美国人已经患有这种残酷、恶性和无法治愈的疾病，全世界有5000万人患有这种可怕的疾病。那是五千万个死刑判决。每年还有一千万人得到它。</blockquote></p><p> The drug industry developed five vaccines in one year for COVID-19, a disease associated with the deaths of 3.7 million people world-wide. Alzheimer’s treatments? Oh, one for every 20 years.</p><p><blockquote>制药行业在一年内为COVID-19开发了五种疫苗，这种疾病导致全球370万人死亡。老年痴呆症的治疗？哦，每20年一次。</blockquote></p><p> Let’s be honest: Many people subconsciously shrug off this issue on the principle that Alzheimer’s will only happen to someone else. Alas, many of the people reading this article are going to get this disease. For many more, your father, mother, wife or husband will get it. Or a sibling or close friend. At which point, the “hey, maybe we should have made this a bigger national priority” argument will strike, but too late to help.</p><p><blockquote>老实说：许多人下意识地对这个问题不屑一顾，认为阿尔茨海默氏症只会发生在别人身上。唉，很多读这篇文章的人都会得这种病。对于更多的人，你的父亲、母亲、妻子或丈夫会得到它。或者兄弟姐妹或密友。在这一点上，“嘿，也许我们应该把这作为一个更大的国家优先事项”的论点将会出现，但为时已晚。</blockquote></p><p> This is the context worth bearing in mind when we hear about drugs getting approved—and, just as importantly, when we hear people demagoguing about “greedy” drug companies and “overpriced” drugs. It’s not just this new Alzheimer’s drug, either.</p><p><blockquote>当我们听到药物获得批准时，同样重要的是，当我们听到人们煽动“贪婪”的制药公司和“定价过高”的药物时，这是值得记住的背景。也不仅仅是这种新的老年痴呆症药物。</blockquote></p><p> If “drug” companies are making out like bandits, someone really has to explain to me why it doesn’t show up in the…er…stock prices. In the past decade, investors the iShares U.S. Pharmaceuticals exchange-traded fundIHE,+0.61%have made far lower returns than they could have done just by randomly picking a bunch of non-pharmaceutical stocks out of the newspaper. These companies have been worse investments than a simple S&amp;P 500SPX,-0.08%index fund like the SPDR S&amp;P 500 ETFSPY,-0.10%,or the Invesco S&amp;P 500 Equal Weight ETFRSP,-0.18%.</p><p><blockquote>如果“毒品”公司像强盗一样亲热，有人真的必须向我解释为什么它没有出现在…呃…股票价格中。在过去的十年里，iShares美国制药交易所交易基金的投资者获得的回报远低于仅仅从报纸上随机挑选一堆非制药股票所能获得的回报。这些公司的投资比简单的标准普尔500SPX，-0.08%指数基金（例如SPDR标普500 ETFSPY，-0.10%）或景顺标普500等权重ETFRSP，-0.18%）更糟糕。</blockquote></p><p> Even Biogen itself had substantially underperformed the broader stock market index for a decade. Until Monday.</p><p><blockquote>十年来，甚至百健（Biogen）本身的表现也大幅落后于大盘指数。直到星期一。</blockquote></p><p> No, the industry returns aren’t terrible. But they are hardly the giant free oil well that critics sometimes suggest. I checked out the data from Dartmouth College finance professor Kenneth French, who has tracked stock market returns by industry going back decades. Going all the way back to the 1920s, according to his numbers, the pharmaceuticals industry barely cracks the top one-third of all industries by stock returns. So far this millennium, the total returns from major pharmaceutical companies have been about a third less than those from the S&amp;P 500 index. Biotechs have done much better, but they were a much smaller sector. And even biotech has trailed the returns of alcohol and tobacco companies.</p><p><blockquote>不，行业回报并不可怕。但它们并不是批评者有时所说的巨大的自由油井。我查阅了达特茅斯学院金融学教授肯尼斯·弗伦奇的数据，他几十年前就按行业追踪了股市回报。根据他的数据，追溯到20世纪20年代，制药业的股票回报率勉强跻身所有行业的前三分之一。本世纪迄今为止，大型制药公司的总回报比标普500指数低约三分之一。生物技术做得更好，但它们是一个小得多的行业。甚至生物技术公司的回报率也落后于酒精和烟草公司。</blockquote></p><p> How are we going to get billions of dollars more capital invested in curing Alzheimer’s and diabetes and cancer when investors can make more money investing in making booze and cigarettes? This is upside down.</p><p><blockquote>当投资者可以通过投资制造酒精和香烟赚更多的钱时，我们如何获得数十亿美元的资本投资于治疗阿尔茨海默氏症、糖尿病和癌症？这是颠倒的。</blockquote></p><p> Meanwhile the regulation are all messed up and back to front as well.This headline says it all: “FDA Approves Alzheimer’s Drug Despite Fierce Debate Over&nbsp;Whether&nbsp;It Works.”</p><p><blockquote>与此同时，规则也被颠倒了。这个标题说明了一切：“尽管对阿尔茨海默氏症药物是否有效存在激烈争论，但FDA还是批准了该药物。”</blockquote></p><p> This is nuts. Maybe the new treatment makes things better, maybe it doesn’t. Apparently people aren’t certain. It’s hardly a surprise: The treatment is new, and the disease is complicated. But the first question to ask isn’t whether it makes things better, but whether it makes things worse. The current situation is catastrophic for anyone with the disease. People are dying. Lives are being destroyed.</p><p><blockquote>这太疯狂了。也许新的治疗方法让事情变得更好，也许没有。显然人们不确定。这并不奇怪：治疗方法是新的，疾病也很复杂。但首先要问的问题不是它是否让事情变得更好，而是它是否让事情变得更糟。目前的情况对任何患有这种疾病的人来说都是灾难性的。人们正在死去。生命正在被摧毁。</blockquote></p><p> Waiting to be sure treatment works would be like falling out of a plane with a parachute on, but hesitating to pull the cord because, well, it might not work. It suggests a basic misunderstanding of game theory. (Or common sense.)</p><p><blockquote>等待确定治疗有效就像带着降落伞从飞机上掉下来，但犹豫着要不要拉绳子，因为，嗯，它可能不起作用。这表明了对博弈论的一个基本误解。（或常识。）</blockquote></p><p> It’s one thing to hesitate about approving a new drug for a nonfatal illness. You don’t want to make people sicker, or cause needless suffering or death. But with this kind of illness that really doesn’t apply.</p><p><blockquote>对批准一种治疗非致命疾病的新药犹豫不决是一回事。你不想让人们病得更重，或者造成不必要的痛苦或死亡。但是这种病真的不适用。</blockquote></p><p></p><p> Anyone who says “oh, no, we need to be really careful, and if need be delay these new treatments for years to make sure they are absolutely 100% safe” is speaking from a position of privilege. They should try saying that to someone watching a loved one be destroyed by the illness. It’s easy to play that card when it’s not happening to you, or someone you love.</p><p><blockquote>任何说“哦，不，我们需要非常小心，如果需要，将这些新的治疗方法推迟数年，以确保它们绝对100%安全”的人都是站在特权的立场上说话。他们应该试着对看着亲人被疾病摧毁的人说这句话。当这张牌没有发生在你或你爱的人身上时，很容易打出这张牌。</blockquote></p><p> A look through the Biogen’s public filings tells the sorry story. This new&nbsp;Alzheimer’s&nbsp;treatment entered Phase 3 trials in 2015—six years ago. Did I mention it took one year to get COVID vaccines to market?</p><p><blockquote>浏览一下百健(Biogen)的公开文件就会发现这个令人遗憾的故事。这种新的阿尔茨海默氏症治疗方法于六年前的2015年进入3期试验。我有没有提到COVID疫苗上市花了一年时间？</blockquote></p><p> Meanwhile, check out all the costs associated with developing this treatment. Biogen struck a collaboration deal with Eisai to work on this drug in 2014. Since then the two of them have spent a total of $1.1 billion on it. If it hadn’t been approved, that’s $1.1 billion down the drain.</p><p><blockquote>同时，检查与开发这种疗法相关的所有费用。Biogen于2014年与卫材达成合作协议，开发该药物。从那以后，他们两人总共为此花费了11亿美元。如果没有获得批准，11亿美元将付诸东流。</blockquote></p><p> I want more of these treatments. And I want them quickly, not every two decades. I want trillions pouring into this industry. And I know that lower returns, and more bureaucracy, aren’t the way to get them.</p><p><blockquote>我想要更多这样的治疗。我想要尽快，而不是每二十年一次。我希望数万亿美元涌入这个行业。我知道更低的回报和更多的官僚主义并不是实现这些目标的方法。</blockquote></p><p> None of this, of course, means blind, passive or foolish naiveté about the drug industry or pricing. Drug manufacturers spend about $160 million a year on lobbying, and people involved in the business donated nearly $30 million a year to politicians running for office. Look through the proxy statements and you’ll see plenty of Big Pharma CEOs living off<i>the fatta the lan</i>(like lots of other CEOs).Yes, of course Medicare should have greater freedom to negotiate drug prices.</p><p><blockquote>当然，所有这些都不意味着对制药行业或定价盲目、被动或愚蠢的天真。药品制造商每年在游说上花费约1.6亿美元，参与该行业的人每年向竞选公职的政治家捐赠近3000万美元。浏览一下委托书，你会发现许多大型制药公司的首席执行官靠<i>法塔局域网</i>（像许多其他首席执行官一样）。是的，医疗保险当然应该有更大的自由来谈判药品价格。</blockquote></p><p> Few people know more about malfeasance and greed in the drug industry than investigative journalist Gerald Posner, who literally wrote the book on it —Pharma: Greed, Lies, and the Poisoning Of America.</p><p><blockquote>很少有人比调查记者杰拉尔德·波斯纳更了解制药业的渎职和贪婪，他写了一本关于制药业的书——制药：贪婪、谎言和美国的中毒。</blockquote></p><p> “Most of the time I agree with your take,” he tells me. “FDA red tape bureaucracy is slow and costly and good R&amp;D can cost a fortune, all with no guarantee of success. So risk takers, i.e. drug companies, should be rewarded with financial incentives.”</p><p><blockquote>“大多数时候我同意你的观点，”他告诉我。“FDA的繁文缛节缓慢且成本高昂，良好的研发可能会花费大量资金，而且无法保证成功。因此，冒险者，即制药公司，应该获得经济激励。”</blockquote></p><p> But, he adds, U.S. drug companies are already getting plenty of help. The U.S. has the longest patent protections of any major economy. He adds that big U.S. pharma companies get huge research support from taxpayers through the National Institute for Health.</p><p><blockquote>但是，他补充说，美国制药公司已经得到了大量帮助。美国是所有主要经济体中专利保护时间最长的国家。他补充说，美国大型制药公司通过美国国立卫生研究院从纳税人那里获得了大量的研究支持。</blockquote></p><p> “From 2010 through 2016, every one of the 210 drugs approved for sale by the FDA were completely or in part funded by the NIH,” he says. The fund came to more than $100 billion, he adds.</p><p><blockquote>“从2010年到2016年，FDA批准销售的210种药物中的每一种都完全或部分由NIH资助，”他说。他补充道，该基金规模超过1000亿美元。</blockquote></p><p> All good points. But I fear that as long as it’s more profitable to invest in cigarettes or booze than it is in curing Alzheimer’s, we will all be left with Plan B for our old age: Hoping and praying we don’t get Alzheimer’s.</p><p><blockquote>都是优点。但我担心，只要投资香烟或酒比治疗阿尔茨海默氏症更有利可图，我们都会为晚年留下B计划：希望并祈祷我们不会得阿尔茨海默氏症。</blockquote></p><p></p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opinion: Only ‘greedy’ drug companies will cure Alzheimer’s<blockquote>观点：只有“贪婪”的制药公司才能治愈阿尔茨海默病</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpinion: Only ‘greedy’ drug companies will cure Alzheimer’s<blockquote>观点：只有“贪婪”的制药公司才能治愈阿尔茨海默病</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">marketwatch</strong><span class=\"h-time small\">2021-06-08 19:59</span>\n</p>\n</h4>\n</header>\n<article>\n<p><img src=\"https://static.tigerbbs.com/783580e857537ceb68ca7c6330ee4132\" tg-width=\"1260\" tg-height=\"736\">Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my fellow members of the (ahem) “mainstream media.”</p><p><blockquote>这里有一个问题要问国会和白宫的每个人，联邦官僚机构，以及我所有的（咳咳）“主流媒体”的同事们。</blockquote></p><p> Now that BiogenBIIB,+38.34%has got approval forits new Alzheimer’s drug—the first approved by the FDA in almost 20 years — how much should they be allowed to charge for it?</p><p><blockquote>既然BiogenBIIB，+38.34%的新药已经获得批准——这是近20年来FDA批准的第一种药物——他们应该被允许收取多少费用？</blockquote></p><p> What’s the ethically correct figure? What will exempt them from charges of “greed” or “gouging?” What is “too much?”</p><p><blockquote>伦理上正确的数字是多少？什么能免除他们“贪婪”或“欺诈”的指控？什么是“太多了？”</blockquote></p><p> The manufacturing cost per pill? The cost plus a small margin? What’s the number?</p><p><blockquote>每粒药丸的制造成本？成本加上一点利润？号码是多少？</blockquote></p><p> I bring this up because few things matter as much for the lives of senior citizens in America—and seniors in the rest of the world—than the development of new drugs. I have personally seen up close how Alzheimer’s destroys people, sometimes as young as their 50s and 60s. This has included close members of my family.</p><p><blockquote>我提出这个问题是因为对于美国老年人——以及世界其他地方的老年人——的生活来说，没有什么比新药的开发更重要的了。我亲眼目睹了老年痴呆症是如何摧毁人的，有时只有五六十岁的人。这包括我的近亲。</blockquote></p><p> Some six million Americans already have this cruel, vicious and incurable disease, and ahorrific 50 million around the world. That’s 50 million death sentences. Ten million more get it every year.</p><p><blockquote>大约600万美国人已经患有这种残酷、恶性和无法治愈的疾病，全世界有5000万人患有这种可怕的疾病。那是五千万个死刑判决。每年还有一千万人得到它。</blockquote></p><p> The drug industry developed five vaccines in one year for COVID-19, a disease associated with the deaths of 3.7 million people world-wide. Alzheimer’s treatments? Oh, one for every 20 years.</p><p><blockquote>制药行业在一年内为COVID-19开发了五种疫苗，这种疾病导致全球370万人死亡。老年痴呆症的治疗？哦，每20年一次。</blockquote></p><p> Let’s be honest: Many people subconsciously shrug off this issue on the principle that Alzheimer’s will only happen to someone else. Alas, many of the people reading this article are going to get this disease. For many more, your father, mother, wife or husband will get it. Or a sibling or close friend. At which point, the “hey, maybe we should have made this a bigger national priority” argument will strike, but too late to help.</p><p><blockquote>老实说：许多人下意识地对这个问题不屑一顾，认为阿尔茨海默氏症只会发生在别人身上。唉，很多读这篇文章的人都会得这种病。对于更多的人，你的父亲、母亲、妻子或丈夫会得到它。或者兄弟姐妹或密友。在这一点上，“嘿，也许我们应该把这作为一个更大的国家优先事项”的论点将会出现，但为时已晚。</blockquote></p><p> This is the context worth bearing in mind when we hear about drugs getting approved—and, just as importantly, when we hear people demagoguing about “greedy” drug companies and “overpriced” drugs. It’s not just this new Alzheimer’s drug, either.</p><p><blockquote>当我们听到药物获得批准时，同样重要的是，当我们听到人们煽动“贪婪”的制药公司和“定价过高”的药物时，这是值得记住的背景。也不仅仅是这种新的老年痴呆症药物。</blockquote></p><p> If “drug” companies are making out like bandits, someone really has to explain to me why it doesn’t show up in the…er…stock prices. In the past decade, investors the iShares U.S. Pharmaceuticals exchange-traded fundIHE,+0.61%have made far lower returns than they could have done just by randomly picking a bunch of non-pharmaceutical stocks out of the newspaper. These companies have been worse investments than a simple S&amp;P 500SPX,-0.08%index fund like the SPDR S&amp;P 500 ETFSPY,-0.10%,or the Invesco S&amp;P 500 Equal Weight ETFRSP,-0.18%.</p><p><blockquote>如果“毒品”公司像强盗一样亲热，有人真的必须向我解释为什么它没有出现在…呃…股票价格中。在过去的十年里，iShares美国制药交易所交易基金的投资者获得的回报远低于仅仅从报纸上随机挑选一堆非制药股票所能获得的回报。这些公司的投资比简单的标准普尔500SPX，-0.08%指数基金（例如SPDR标普500 ETFSPY，-0.10%）或景顺标普500等权重ETFRSP，-0.18%）更糟糕。</blockquote></p><p> Even Biogen itself had substantially underperformed the broader stock market index for a decade. Until Monday.</p><p><blockquote>十年来，甚至百健（Biogen）本身的表现也大幅落后于大盘指数。直到星期一。</blockquote></p><p> No, the industry returns aren’t terrible. But they are hardly the giant free oil well that critics sometimes suggest. I checked out the data from Dartmouth College finance professor Kenneth French, who has tracked stock market returns by industry going back decades. Going all the way back to the 1920s, according to his numbers, the pharmaceuticals industry barely cracks the top one-third of all industries by stock returns. So far this millennium, the total returns from major pharmaceutical companies have been about a third less than those from the S&amp;P 500 index. Biotechs have done much better, but they were a much smaller sector. And even biotech has trailed the returns of alcohol and tobacco companies.</p><p><blockquote>不，行业回报并不可怕。但它们并不是批评者有时所说的巨大的自由油井。我查阅了达特茅斯学院金融学教授肯尼斯·弗伦奇的数据，他几十年前就按行业追踪了股市回报。根据他的数据，追溯到20世纪20年代，制药业的股票回报率勉强跻身所有行业的前三分之一。本世纪迄今为止，大型制药公司的总回报比标普500指数低约三分之一。生物技术做得更好，但它们是一个小得多的行业。甚至生物技术公司的回报率也落后于酒精和烟草公司。</blockquote></p><p> How are we going to get billions of dollars more capital invested in curing Alzheimer’s and diabetes and cancer when investors can make more money investing in making booze and cigarettes? This is upside down.</p><p><blockquote>当投资者可以通过投资制造酒精和香烟赚更多的钱时，我们如何获得数十亿美元的资本投资于治疗阿尔茨海默氏症、糖尿病和癌症？这是颠倒的。</blockquote></p><p> Meanwhile the regulation are all messed up and back to front as well.This headline says it all: “FDA Approves Alzheimer’s Drug Despite Fierce Debate Over&nbsp;Whether&nbsp;It Works.”</p><p><blockquote>与此同时，规则也被颠倒了。这个标题说明了一切：“尽管对阿尔茨海默氏症药物是否有效存在激烈争论，但FDA还是批准了该药物。”</blockquote></p><p> This is nuts. Maybe the new treatment makes things better, maybe it doesn’t. Apparently people aren’t certain. It’s hardly a surprise: The treatment is new, and the disease is complicated. But the first question to ask isn’t whether it makes things better, but whether it makes things worse. The current situation is catastrophic for anyone with the disease. People are dying. Lives are being destroyed.</p><p><blockquote>这太疯狂了。也许新的治疗方法让事情变得更好，也许没有。显然人们不确定。这并不奇怪：治疗方法是新的，疾病也很复杂。但首先要问的问题不是它是否让事情变得更好，而是它是否让事情变得更糟。目前的情况对任何患有这种疾病的人来说都是灾难性的。人们正在死去。生命正在被摧毁。</blockquote></p><p> Waiting to be sure treatment works would be like falling out of a plane with a parachute on, but hesitating to pull the cord because, well, it might not work. It suggests a basic misunderstanding of game theory. (Or common sense.)</p><p><blockquote>等待确定治疗有效就像带着降落伞从飞机上掉下来，但犹豫着要不要拉绳子，因为，嗯，它可能不起作用。这表明了对博弈论的一个基本误解。（或常识。）</blockquote></p><p> It’s one thing to hesitate about approving a new drug for a nonfatal illness. You don’t want to make people sicker, or cause needless suffering or death. But with this kind of illness that really doesn’t apply.</p><p><blockquote>对批准一种治疗非致命疾病的新药犹豫不决是一回事。你不想让人们病得更重，或者造成不必要的痛苦或死亡。但是这种病真的不适用。</blockquote></p><p></p><p> Anyone who says “oh, no, we need to be really careful, and if need be delay these new treatments for years to make sure they are absolutely 100% safe” is speaking from a position of privilege. They should try saying that to someone watching a loved one be destroyed by the illness. It’s easy to play that card when it’s not happening to you, or someone you love.</p><p><blockquote>任何说“哦，不，我们需要非常小心，如果需要，将这些新的治疗方法推迟数年，以确保它们绝对100%安全”的人都是站在特权的立场上说话。他们应该试着对看着亲人被疾病摧毁的人说这句话。当这张牌没有发生在你或你爱的人身上时，很容易打出这张牌。</blockquote></p><p> A look through the Biogen’s public filings tells the sorry story. This new&nbsp;Alzheimer’s&nbsp;treatment entered Phase 3 trials in 2015—six years ago. Did I mention it took one year to get COVID vaccines to market?</p><p><blockquote>浏览一下百健(Biogen)的公开文件就会发现这个令人遗憾的故事。这种新的阿尔茨海默氏症治疗方法于六年前的2015年进入3期试验。我有没有提到COVID疫苗上市花了一年时间？</blockquote></p><p> Meanwhile, check out all the costs associated with developing this treatment. Biogen struck a collaboration deal with Eisai to work on this drug in 2014. Since then the two of them have spent a total of $1.1 billion on it. If it hadn’t been approved, that’s $1.1 billion down the drain.</p><p><blockquote>同时，检查与开发这种疗法相关的所有费用。Biogen于2014年与卫材达成合作协议，开发该药物。从那以后，他们两人总共为此花费了11亿美元。如果没有获得批准，11亿美元将付诸东流。</blockquote></p><p> I want more of these treatments. And I want them quickly, not every two decades. I want trillions pouring into this industry. And I know that lower returns, and more bureaucracy, aren’t the way to get them.</p><p><blockquote>我想要更多这样的治疗。我想要尽快，而不是每二十年一次。我希望数万亿美元涌入这个行业。我知道更低的回报和更多的官僚主义并不是实现这些目标的方法。</blockquote></p><p> None of this, of course, means blind, passive or foolish naiveté about the drug industry or pricing. Drug manufacturers spend about $160 million a year on lobbying, and people involved in the business donated nearly $30 million a year to politicians running for office. Look through the proxy statements and you’ll see plenty of Big Pharma CEOs living off<i>the fatta the lan</i>(like lots of other CEOs).Yes, of course Medicare should have greater freedom to negotiate drug prices.</p><p><blockquote>当然，所有这些都不意味着对制药行业或定价盲目、被动或愚蠢的天真。药品制造商每年在游说上花费约1.6亿美元，参与该行业的人每年向竞选公职的政治家捐赠近3000万美元。浏览一下委托书，你会发现许多大型制药公司的首席执行官靠<i>法塔局域网</i>（像许多其他首席执行官一样）。是的，医疗保险当然应该有更大的自由来谈判药品价格。</blockquote></p><p> Few people know more about malfeasance and greed in the drug industry than investigative journalist Gerald Posner, who literally wrote the book on it —Pharma: Greed, Lies, and the Poisoning Of America.</p><p><blockquote>很少有人比调查记者杰拉尔德·波斯纳更了解制药业的渎职和贪婪，他写了一本关于制药业的书——制药：贪婪、谎言和美国的中毒。</blockquote></p><p> “Most of the time I agree with your take,” he tells me. “FDA red tape bureaucracy is slow and costly and good R&amp;D can cost a fortune, all with no guarantee of success. So risk takers, i.e. drug companies, should be rewarded with financial incentives.”</p><p><blockquote>“大多数时候我同意你的观点，”他告诉我。“FDA的繁文缛节缓慢且成本高昂，良好的研发可能会花费大量资金，而且无法保证成功。因此，冒险者，即制药公司，应该获得经济激励。”</blockquote></p><p> But, he adds, U.S. drug companies are already getting plenty of help. The U.S. has the longest patent protections of any major economy. He adds that big U.S. pharma companies get huge research support from taxpayers through the National Institute for Health.</p><p><blockquote>但是，他补充说，美国制药公司已经得到了大量帮助。美国是所有主要经济体中专利保护时间最长的国家。他补充说，美国大型制药公司通过美国国立卫生研究院从纳税人那里获得了大量的研究支持。</blockquote></p><p> “From 2010 through 2016, every one of the 210 drugs approved for sale by the FDA were completely or in part funded by the NIH,” he says. The fund came to more than $100 billion, he adds.</p><p><blockquote>“从2010年到2016年，FDA批准销售的210种药物中的每一种都完全或部分由NIH资助，”他说。他补充道，该基金规模超过1000亿美元。</blockquote></p><p> All good points. But I fear that as long as it’s more profitable to invest in cigarettes or booze than it is in curing Alzheimer’s, we will all be left with Plan B for our old age: Hoping and praying we don’t get Alzheimer’s.</p><p><blockquote>都是优点。但我担心，只要投资香烟或酒比治疗阿尔茨海默氏症更有利可图，我们都会为晚年留下B计划：希望并祈祷我们不会得阿尔茨海默氏症。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/only-greedy-drug-companies-will-cure-alzheimers-11623152892?mod=newsviewer_click\">marketwatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.marketwatch.com/story/only-greedy-drug-companies-will-cure-alzheimers-11623152892?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1127979401","content_text":"Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my fellow members of the (ahem) “mainstream media.”\nNow that BiogenBIIB,+38.34%has got approval forits new Alzheimer’s drug—the first approved by the FDA in almost 20 years — how much should they be allowed to charge for it?\nWhat’s the ethically correct figure? What will exempt them from charges of “greed” or “gouging?” What is “too much?”\nThe manufacturing cost per pill? The cost plus a small margin? What’s the number?\nI bring this up because few things matter as much for the lives of senior citizens in America—and seniors in the rest of the world—than the development of new drugs. I have personally seen up close how Alzheimer’s destroys people, sometimes as young as their 50s and 60s. This has included close members of my family.\nSome six million Americans already have this cruel, vicious and incurable disease, and ahorrific 50 million around the world. That’s 50 million death sentences. Ten million more get it every year.\nThe drug industry developed five vaccines in one year for COVID-19, a disease associated with the deaths of 3.7 million people world-wide. Alzheimer’s treatments? Oh, one for every 20 years.\nLet’s be honest: Many people subconsciously shrug off this issue on the principle that Alzheimer’s will only happen to someone else. Alas, many of the people reading this article are going to get this disease. For many more, your father, mother, wife or husband will get it. Or a sibling or close friend. At which point, the “hey, maybe we should have made this a bigger national priority” argument will strike, but too late to help.\nThis is the context worth bearing in mind when we hear about drugs getting approved—and, just as importantly, when we hear people demagoguing about “greedy” drug companies and “overpriced” drugs. It’s not just this new Alzheimer’s drug, either.\nIf “drug” companies are making out like bandits, someone really has to explain to me why it doesn’t show up in the…er…stock prices. In the past decade, investors the iShares U.S. Pharmaceuticals exchange-traded fundIHE,+0.61%have made far lower returns than they could have done just by randomly picking a bunch of non-pharmaceutical stocks out of the newspaper. These companies have been worse investments than a simple S&P 500SPX,-0.08%index fund like the SPDR S&P 500 ETFSPY,-0.10%,or the Invesco S&P 500 Equal Weight ETFRSP,-0.18%.\nEven Biogen itself had substantially underperformed the broader stock market index for a decade. Until Monday.\nNo, the industry returns aren’t terrible. But they are hardly the giant free oil well that critics sometimes suggest. I checked out the data from Dartmouth College finance professor Kenneth French, who has tracked stock market returns by industry going back decades. Going all the way back to the 1920s, according to his numbers, the pharmaceuticals industry barely cracks the top one-third of all industries by stock returns. So far this millennium, the total returns from major pharmaceutical companies have been about a third less than those from the S&P 500 index. Biotechs have done much better, but they were a much smaller sector. And even biotech has trailed the returns of alcohol and tobacco companies.\nHow are we going to get billions of dollars more capital invested in curing Alzheimer’s and diabetes and cancer when investors can make more money investing in making booze and cigarettes? This is upside down.\nMeanwhile the regulation are all messed up and back to front as well.This headline says it all: “FDA Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works.”\nThis is nuts. Maybe the new treatment makes things better, maybe it doesn’t. Apparently people aren’t certain. It’s hardly a surprise: The treatment is new, and the disease is complicated. But the first question to ask isn’t whether it makes things better, but whether it makes things worse. The current situation is catastrophic for anyone with the disease. People are dying. Lives are being destroyed.\nWaiting to be sure treatment works would be like falling out of a plane with a parachute on, but hesitating to pull the cord because, well, it might not work. It suggests a basic misunderstanding of game theory. (Or common sense.)\nIt’s one thing to hesitate about approving a new drug for a nonfatal illness. You don’t want to make people sicker, or cause needless suffering or death. But with this kind of illness that really doesn’t apply.\nAnyone who says “oh, no, we need to be really careful, and if need be delay these new treatments for years to make sure they are absolutely 100% safe” is speaking from a position of privilege. They should try saying that to someone watching a loved one be destroyed by the illness. It’s easy to play that card when it’s not happening to you, or someone you love.\nA look through the Biogen’s public filings tells the sorry story. This new Alzheimer’s treatment entered Phase 3 trials in 2015—six years ago. Did I mention it took one year to get COVID vaccines to market?\nMeanwhile, check out all the costs associated with developing this treatment. Biogen struck a collaboration deal with Eisai to work on this drug in 2014. Since then the two of them have spent a total of $1.1 billion on it. If it hadn’t been approved, that’s $1.1 billion down the drain.\nI want more of these treatments. And I want them quickly, not every two decades. I want trillions pouring into this industry. And I know that lower returns, and more bureaucracy, aren’t the way to get them.\nNone of this, of course, means blind, passive or foolish naiveté about the drug industry or pricing. Drug manufacturers spend about $160 million a year on lobbying, and people involved in the business donated nearly $30 million a year to politicians running for office. Look through the proxy statements and you’ll see plenty of Big Pharma CEOs living offthe fatta the lan(like lots of other CEOs).Yes, of course Medicare should have greater freedom to negotiate drug prices.\nFew people know more about malfeasance and greed in the drug industry than investigative journalist Gerald Posner, who literally wrote the book on it —Pharma: Greed, Lies, and the Poisoning Of America.\n“Most of the time I agree with your take,” he tells me. “FDA red tape bureaucracy is slow and costly and good R&D can cost a fortune, all with no guarantee of success. So risk takers, i.e. drug companies, should be rewarded with financial incentives.”\nBut, he adds, U.S. drug companies are already getting plenty of help. The U.S. has the longest patent protections of any major economy. He adds that big U.S. pharma companies get huge research support from taxpayers through the National Institute for Health.\n“From 2010 through 2016, every one of the 210 drugs approved for sale by the FDA were completely or in part funded by the NIH,” he says. The fund came to more than $100 billion, he adds.\nAll good points. But I fear that as long as it’s more profitable to invest in cigarettes or booze than it is in curing Alzheimer’s, we will all be left with Plan B for our old age: Hoping and praying we don’t get Alzheimer’s.","news_type":1,"symbols_score_info":{"BIIB":0.9}},"isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114285077,"gmtCreate":1623075562299,"gmtModify":1634037219001,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Hmmmm","listText":"Hmmmm","text":"Hmmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/114285077","repostId":"1126396501","repostType":4,"isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114067750,"gmtCreate":1623036984970,"gmtModify":1634095984428,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Not bad","listText":"Not bad","text":"Not bad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/114067750","repostId":"1144781953","repostType":4,"repost":{"id":"1144781953","kind":"news","pubTimestamp":1623029453,"share":"https://www.laohu8.com/m/news/1144781953?lang=zh_CN&edition=full","pubTime":"2021-06-07 09:30","market":"fut","language":"en","title":"WTI Oil Tops $70 for First Time Since 2018 as Market Tightens<blockquote>随着市场收紧，WTI油价自2018年以来首次突破70美元</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1144781953","media":"Bloomberg","summary":"(Bloomberg) -- Oil in New York topped $70 a barrel for the first time since October 2018 as upbeat c","content":"<p>(Bloomberg) -- Oil in New York topped $70 a barrel for the first time since October 2018 as upbeat comments on the market from major trader Vitol Group added to optimism over the global demand recovery.</p><p><blockquote>（彭博社）-纽约油价自2018年10月以来首次突破每桶70美元，主要交易商维多集团对市场的乐观评论增加了对全球需求复苏的乐观情绪。</blockquote></p><p>Futures rose as much as 0.6% after posting a second weekly gain, while global Brent traded above $72 a barrel. OPEC+ appears in control of crude prices, with U.S. production lagging pre-pandemic levels, Mike Muller, Vitol’s head of Asia, said at a conference on Sunday. The alliance is returning supply after output cuts helped to tighten the market.</p><p><blockquote>期货价格在连续第二周上涨后上涨0.6%，而全球布伦特原油价格高于每桶72美元。Vitol亚洲主管Mike Muller在周日的一次会议上表示，OPEC+似乎控制了原油价格，美国的产量落后于大流行前的水平。在减产导致市场收紧后，该联盟正在恢复供应。</blockquote></p><p>A robust rebound from the virus in the U.S., China and Europe has driven prices more than 40% higher this year, although the Covid-19 comeback in Asia is a reminder that the recovery will be uneven. Russia’s Rosneft PJSC, meanwhile, warned of an impending shortfall in supply as global producers increasingly channel funds into a “hasty” energy transition.</p><p><blockquote>美国、中国和欧洲从病毒中的强劲反弹推动今年价格上涨了40%以上，尽管新冠肺炎在亚洲的卷土重来提醒人们复苏将是不平衡的。与此同时，俄罗斯石油公司（Rosneft PJSC）警告称，随着全球生产商越来越多地将资金投入“仓促”的能源转型，供应即将出现短缺。</blockquote></p><p>“I expect crude oil to continue to push higher,” said Daniel Hynes, senior commodities strategist at Australia and New Zealand Banking Group Ltd. “The focus remains on demand, with traffic data suggesting the summer driving season should be positive.”</p><p><blockquote>澳大利亚和新西兰银行集团有限公司高级大宗商品策略师Daniel Hynes表示：“我预计原油将继续走高。”“重点仍然是需求，交通数据表明夏季驾驶季节应该是积极的。”</blockquote></p><p>The market has firmed in a bullish structure. The prompt timespread for Brent is 41 cents in backwardation -- where near-dated prices are more expensive than later-dated ones. That compares with 37 cents a week earlier.</p><p><blockquote>市场在看涨结构中企稳。布伦特原油的即时价差为现货溢价41美分，近期价格比近期价格贵。相比之下，一周前为37美分。</blockquote></p><p>The decline in U.S. drilling and output makes OPEC+’s job of managing markets easier, Vitol’s Muller said at an event hosted by consultant Gulf Intelligence. Given delays in talks between Tehran and world powers on reviving a nuclear deal, it’s less likely more Iranian crude supply will hit the market before the fourth quarter, he added.</p><p><blockquote>Vitol的Muller在咨询公司Gulf Intelligence主办的一次活动中表示，美国钻探和产量的下降使OPEC+管理市场的工作变得更加容易。他补充说，鉴于德黑兰与世界大国就恢复核协议进行的谈判推迟，在第四季度之前，更多伊朗原油供应不太可能进入市场。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WTI Oil Tops $70 for First Time Since 2018 as Market Tightens<blockquote>随着市场收紧，WTI油价自2018年以来首次突破70美元</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWTI Oil Tops $70 for First Time Since 2018 as Market Tightens<blockquote>随着市场收紧，WTI油价自2018年以来首次突破70美元</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-06-07 09:30</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- Oil in New York topped $70 a barrel for the first time since October 2018 as upbeat comments on the market from major trader Vitol Group added to optimism over the global demand recovery.</p><p><blockquote>（彭博社）-纽约油价自2018年10月以来首次突破每桶70美元，主要交易商维多集团对市场的乐观评论增加了对全球需求复苏的乐观情绪。</blockquote></p><p>Futures rose as much as 0.6% after posting a second weekly gain, while global Brent traded above $72 a barrel. OPEC+ appears in control of crude prices, with U.S. production lagging pre-pandemic levels, Mike Muller, Vitol’s head of Asia, said at a conference on Sunday. The alliance is returning supply after output cuts helped to tighten the market.</p><p><blockquote>期货价格在连续第二周上涨后上涨0.6%，而全球布伦特原油价格高于每桶72美元。Vitol亚洲主管Mike Muller在周日的一次会议上表示，OPEC+似乎控制了原油价格，美国的产量落后于大流行前的水平。在减产导致市场收紧后，该联盟正在恢复供应。</blockquote></p><p>A robust rebound from the virus in the U.S., China and Europe has driven prices more than 40% higher this year, although the Covid-19 comeback in Asia is a reminder that the recovery will be uneven. Russia’s Rosneft PJSC, meanwhile, warned of an impending shortfall in supply as global producers increasingly channel funds into a “hasty” energy transition.</p><p><blockquote>美国、中国和欧洲从病毒中的强劲反弹推动今年价格上涨了40%以上，尽管新冠肺炎在亚洲的卷土重来提醒人们复苏将是不平衡的。与此同时，俄罗斯石油公司（Rosneft PJSC）警告称，随着全球生产商越来越多地将资金投入“仓促”的能源转型，供应即将出现短缺。</blockquote></p><p>“I expect crude oil to continue to push higher,” said Daniel Hynes, senior commodities strategist at Australia and New Zealand Banking Group Ltd. “The focus remains on demand, with traffic data suggesting the summer driving season should be positive.”</p><p><blockquote>澳大利亚和新西兰银行集团有限公司高级大宗商品策略师Daniel Hynes表示：“我预计原油将继续走高。”“重点仍然是需求，交通数据表明夏季驾驶季节应该是积极的。”</blockquote></p><p>The market has firmed in a bullish structure. The prompt timespread for Brent is 41 cents in backwardation -- where near-dated prices are more expensive than later-dated ones. That compares with 37 cents a week earlier.</p><p><blockquote>市场在看涨结构中企稳。布伦特原油的即时价差为现货溢价41美分，近期价格比近期价格贵。相比之下，一周前为37美分。</blockquote></p><p>The decline in U.S. drilling and output makes OPEC+’s job of managing markets easier, Vitol’s Muller said at an event hosted by consultant Gulf Intelligence. Given delays in talks between Tehran and world powers on reviving a nuclear deal, it’s less likely more Iranian crude supply will hit the market before the fourth quarter, he added.</p><p><blockquote>Vitol的Muller在咨询公司Gulf Intelligence主办的一次活动中表示，美国钻探和产量的下降使OPEC+管理市场的工作变得更加容易。他补充说，鉴于德黑兰与世界大国就恢复核协议进行的谈判推迟，在第四季度之前，更多伊朗原油供应不太可能进入市场。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/oil-steady-near-2018-high-230212928.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/oil-steady-near-2018-high-230212928.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144781953","content_text":"(Bloomberg) -- Oil in New York topped $70 a barrel for the first time since October 2018 as upbeat comments on the market from major trader Vitol Group added to optimism over the global demand recovery.Futures rose as much as 0.6% after posting a second weekly gain, while global Brent traded above $72 a barrel. OPEC+ appears in control of crude prices, with U.S. production lagging pre-pandemic levels, Mike Muller, Vitol’s head of Asia, said at a conference on Sunday. The alliance is returning supply after output cuts helped to tighten the market.A robust rebound from the virus in the U.S., China and Europe has driven prices more than 40% higher this year, although the Covid-19 comeback in Asia is a reminder that the recovery will be uneven. Russia’s Rosneft PJSC, meanwhile, warned of an impending shortfall in supply as global producers increasingly channel funds into a “hasty” energy transition.“I expect crude oil to continue to push higher,” said Daniel Hynes, senior commodities strategist at Australia and New Zealand Banking Group Ltd. “The focus remains on demand, with traffic data suggesting the summer driving season should be positive.”The market has firmed in a bullish structure. The prompt timespread for Brent is 41 cents in backwardation -- where near-dated prices are more expensive than later-dated ones. That compares with 37 cents a week earlier.The decline in U.S. drilling and output makes OPEC+’s job of managing markets easier, Vitol’s Muller said at an event hosted by consultant Gulf Intelligence. Given delays in talks between Tehran and world powers on reviving a nuclear deal, it’s less likely more Iranian crude supply will hit the market before the fourth quarter, he added.","news_type":1,"symbols_score_info":{"CLmain":0.9}},"isVote":1,"tweetType":1,"viewCount":649,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114067997,"gmtCreate":1623036925419,"gmtModify":1634095984996,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582279635767115","idStr":"3582279635767115"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/114067997","repostId":"1143555139","repostType":4,"isVote":1,"tweetType":1,"viewCount":316,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":117542129,"gmtCreate":1623154023161,"gmtModify":1634036405390,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Please like and comment for me","listText":"Please like and comment for me","text":"Please like and comment for me","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/117542129","repostId":"1154765176","repostType":4,"isVote":1,"tweetType":1,"viewCount":602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185221565,"gmtCreate":1623654921057,"gmtModify":1631893946625,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Pls comment and like with many thanks","listText":"Pls comment and like with many thanks","text":"Pls comment and like with many thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/185221565","repostId":"1146430910","repostType":4,"isVote":1,"tweetType":1,"viewCount":1454,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120825133,"gmtCreate":1624319468622,"gmtModify":1631893946608,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/120825133","repostId":"1167650307","repostType":4,"isVote":1,"tweetType":1,"viewCount":1482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188293635,"gmtCreate":1623441824927,"gmtModify":1634033168950,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/188293635","repostId":"2142572209","repostType":4,"isVote":1,"tweetType":1,"viewCount":412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115280689,"gmtCreate":1623000672641,"gmtModify":1634096329589,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Yea","listText":"Yea","text":"Yea","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/115280689","repostId":"1156802172","repostType":4,"isVote":1,"tweetType":1,"viewCount":655,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129947356,"gmtCreate":1624354790375,"gmtModify":1631893946605,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Like and comment.&nbsp; Thank you","listText":"Like and comment.&nbsp; Thank you","text":"Like and comment. Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/129947356","repostId":"1186919064","repostType":4,"isVote":1,"tweetType":1,"viewCount":1063,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161037621,"gmtCreate":1623896069063,"gmtModify":1631893946617,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Like and comment pls. Thanks 😊","listText":"Like and comment pls. Thanks 😊","text":"Like and comment pls. Thanks 😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/161037621","repostId":"2144130887","repostType":4,"isVote":1,"tweetType":1,"viewCount":1314,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117543634,"gmtCreate":1623153771328,"gmtModify":1634036407976,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/117543634","repostId":"1127979401","repostType":4,"repost":{"id":"1127979401","kind":"news","pubTimestamp":1623153568,"share":"https://www.laohu8.com/m/news/1127979401?lang=zh_CN&edition=full","pubTime":"2021-06-08 19:59","market":"us","language":"en","title":"Opinion: Only ‘greedy’ drug companies will cure Alzheimer’s<blockquote>观点：只有“贪婪”的制药公司才能治愈阿尔茨海默病</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1127979401","media":"marketwatch","summary":"Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my ","content":"<p><img src=\"https://static.tigerbbs.com/783580e857537ceb68ca7c6330ee4132\" tg-width=\"1260\" tg-height=\"736\">Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my fellow members of the (ahem) “mainstream media.”</p><p><blockquote>这里有一个问题要问国会和白宫的每个人，联邦官僚机构，以及我所有的（咳咳）“主流媒体”的同事们。</blockquote></p><p> Now that BiogenBIIB,+38.34%has got approval forits new Alzheimer’s drug—the first approved by the FDA in almost 20 years — how much should they be allowed to charge for it?</p><p><blockquote>既然BiogenBIIB，+38.34%的新药已经获得批准——这是近20年来FDA批准的第一种药物——他们应该被允许收取多少费用？</blockquote></p><p> What’s the ethically correct figure? What will exempt them from charges of “greed” or “gouging?” What is “too much?”</p><p><blockquote>伦理上正确的数字是多少？什么能免除他们“贪婪”或“欺诈”的指控？什么是“太多了？”</blockquote></p><p> The manufacturing cost per pill? The cost plus a small margin? What’s the number?</p><p><blockquote>每粒药丸的制造成本？成本加上一点利润？号码是多少？</blockquote></p><p> I bring this up because few things matter as much for the lives of senior citizens in America—and seniors in the rest of the world—than the development of new drugs. I have personally seen up close how Alzheimer’s destroys people, sometimes as young as their 50s and 60s. This has included close members of my family.</p><p><blockquote>我提出这个问题是因为对于美国老年人——以及世界其他地方的老年人——的生活来说，没有什么比新药的开发更重要的了。我亲眼目睹了老年痴呆症是如何摧毁人的，有时只有五六十岁的人。这包括我的近亲。</blockquote></p><p> Some six million Americans already have this cruel, vicious and incurable disease, and ahorrific 50 million around the world. That’s 50 million death sentences. Ten million more get it every year.</p><p><blockquote>大约600万美国人已经患有这种残酷、恶性和无法治愈的疾病，全世界有5000万人患有这种可怕的疾病。那是五千万个死刑判决。每年还有一千万人得到它。</blockquote></p><p> The drug industry developed five vaccines in one year for COVID-19, a disease associated with the deaths of 3.7 million people world-wide. Alzheimer’s treatments? Oh, one for every 20 years.</p><p><blockquote>制药行业在一年内为COVID-19开发了五种疫苗，这种疾病导致全球370万人死亡。老年痴呆症的治疗？哦，每20年一次。</blockquote></p><p> Let’s be honest: Many people subconsciously shrug off this issue on the principle that Alzheimer’s will only happen to someone else. Alas, many of the people reading this article are going to get this disease. For many more, your father, mother, wife or husband will get it. Or a sibling or close friend. At which point, the “hey, maybe we should have made this a bigger national priority” argument will strike, but too late to help.</p><p><blockquote>老实说：许多人下意识地对这个问题不屑一顾，认为阿尔茨海默氏症只会发生在别人身上。唉，很多读这篇文章的人都会得这种病。对于更多的人，你的父亲、母亲、妻子或丈夫会得到它。或者兄弟姐妹或密友。在这一点上，“嘿，也许我们应该把这作为一个更大的国家优先事项”的论点将会出现，但为时已晚。</blockquote></p><p> This is the context worth bearing in mind when we hear about drugs getting approved—and, just as importantly, when we hear people demagoguing about “greedy” drug companies and “overpriced” drugs. It’s not just this new Alzheimer’s drug, either.</p><p><blockquote>当我们听到药物获得批准时，同样重要的是，当我们听到人们煽动“贪婪”的制药公司和“定价过高”的药物时，这是值得记住的背景。也不仅仅是这种新的老年痴呆症药物。</blockquote></p><p> If “drug” companies are making out like bandits, someone really has to explain to me why it doesn’t show up in the…er…stock prices. In the past decade, investors the iShares U.S. Pharmaceuticals exchange-traded fundIHE,+0.61%have made far lower returns than they could have done just by randomly picking a bunch of non-pharmaceutical stocks out of the newspaper. These companies have been worse investments than a simple S&amp;P 500SPX,-0.08%index fund like the SPDR S&amp;P 500 ETFSPY,-0.10%,or the Invesco S&amp;P 500 Equal Weight ETFRSP,-0.18%.</p><p><blockquote>如果“毒品”公司像强盗一样亲热，有人真的必须向我解释为什么它没有出现在…呃…股票价格中。在过去的十年里，iShares美国制药交易所交易基金的投资者获得的回报远低于仅仅从报纸上随机挑选一堆非制药股票所能获得的回报。这些公司的投资比简单的标准普尔500SPX，-0.08%指数基金（例如SPDR标普500 ETFSPY，-0.10%）或景顺标普500等权重ETFRSP，-0.18%）更糟糕。</blockquote></p><p> Even Biogen itself had substantially underperformed the broader stock market index for a decade. Until Monday.</p><p><blockquote>十年来，甚至百健（Biogen）本身的表现也大幅落后于大盘指数。直到星期一。</blockquote></p><p> No, the industry returns aren’t terrible. But they are hardly the giant free oil well that critics sometimes suggest. I checked out the data from Dartmouth College finance professor Kenneth French, who has tracked stock market returns by industry going back decades. Going all the way back to the 1920s, according to his numbers, the pharmaceuticals industry barely cracks the top one-third of all industries by stock returns. So far this millennium, the total returns from major pharmaceutical companies have been about a third less than those from the S&amp;P 500 index. Biotechs have done much better, but they were a much smaller sector. And even biotech has trailed the returns of alcohol and tobacco companies.</p><p><blockquote>不，行业回报并不可怕。但它们并不是批评者有时所说的巨大的自由油井。我查阅了达特茅斯学院金融学教授肯尼斯·弗伦奇的数据，他几十年前就按行业追踪了股市回报。根据他的数据，追溯到20世纪20年代，制药业的股票回报率勉强跻身所有行业的前三分之一。本世纪迄今为止，大型制药公司的总回报比标普500指数低约三分之一。生物技术做得更好，但它们是一个小得多的行业。甚至生物技术公司的回报率也落后于酒精和烟草公司。</blockquote></p><p> How are we going to get billions of dollars more capital invested in curing Alzheimer’s and diabetes and cancer when investors can make more money investing in making booze and cigarettes? This is upside down.</p><p><blockquote>当投资者可以通过投资制造酒精和香烟赚更多的钱时，我们如何获得数十亿美元的资本投资于治疗阿尔茨海默氏症、糖尿病和癌症？这是颠倒的。</blockquote></p><p> Meanwhile the regulation are all messed up and back to front as well.This headline says it all: “FDA Approves Alzheimer’s Drug Despite Fierce Debate Over&nbsp;Whether&nbsp;It Works.”</p><p><blockquote>与此同时，规则也被颠倒了。这个标题说明了一切：“尽管对阿尔茨海默氏症药物是否有效存在激烈争论，但FDA还是批准了该药物。”</blockquote></p><p> This is nuts. Maybe the new treatment makes things better, maybe it doesn’t. Apparently people aren’t certain. It’s hardly a surprise: The treatment is new, and the disease is complicated. But the first question to ask isn’t whether it makes things better, but whether it makes things worse. The current situation is catastrophic for anyone with the disease. People are dying. Lives are being destroyed.</p><p><blockquote>这太疯狂了。也许新的治疗方法让事情变得更好，也许没有。显然人们不确定。这并不奇怪：治疗方法是新的，疾病也很复杂。但首先要问的问题不是它是否让事情变得更好，而是它是否让事情变得更糟。目前的情况对任何患有这种疾病的人来说都是灾难性的。人们正在死去。生命正在被摧毁。</blockquote></p><p> Waiting to be sure treatment works would be like falling out of a plane with a parachute on, but hesitating to pull the cord because, well, it might not work. It suggests a basic misunderstanding of game theory. (Or common sense.)</p><p><blockquote>等待确定治疗有效就像带着降落伞从飞机上掉下来，但犹豫着要不要拉绳子，因为，嗯，它可能不起作用。这表明了对博弈论的一个基本误解。（或常识。）</blockquote></p><p> It’s one thing to hesitate about approving a new drug for a nonfatal illness. You don’t want to make people sicker, or cause needless suffering or death. But with this kind of illness that really doesn’t apply.</p><p><blockquote>对批准一种治疗非致命疾病的新药犹豫不决是一回事。你不想让人们病得更重，或者造成不必要的痛苦或死亡。但是这种病真的不适用。</blockquote></p><p></p><p> Anyone who says “oh, no, we need to be really careful, and if need be delay these new treatments for years to make sure they are absolutely 100% safe” is speaking from a position of privilege. They should try saying that to someone watching a loved one be destroyed by the illness. It’s easy to play that card when it’s not happening to you, or someone you love.</p><p><blockquote>任何说“哦，不，我们需要非常小心，如果需要，将这些新的治疗方法推迟数年，以确保它们绝对100%安全”的人都是站在特权的立场上说话。他们应该试着对看着亲人被疾病摧毁的人说这句话。当这张牌没有发生在你或你爱的人身上时，很容易打出这张牌。</blockquote></p><p> A look through the Biogen’s public filings tells the sorry story. This new&nbsp;Alzheimer’s&nbsp;treatment entered Phase 3 trials in 2015—six years ago. Did I mention it took one year to get COVID vaccines to market?</p><p><blockquote>浏览一下百健(Biogen)的公开文件就会发现这个令人遗憾的故事。这种新的阿尔茨海默氏症治疗方法于六年前的2015年进入3期试验。我有没有提到COVID疫苗上市花了一年时间？</blockquote></p><p> Meanwhile, check out all the costs associated with developing this treatment. Biogen struck a collaboration deal with Eisai to work on this drug in 2014. Since then the two of them have spent a total of $1.1 billion on it. If it hadn’t been approved, that’s $1.1 billion down the drain.</p><p><blockquote>同时，检查与开发这种疗法相关的所有费用。Biogen于2014年与卫材达成合作协议，开发该药物。从那以后，他们两人总共为此花费了11亿美元。如果没有获得批准，11亿美元将付诸东流。</blockquote></p><p> I want more of these treatments. And I want them quickly, not every two decades. I want trillions pouring into this industry. And I know that lower returns, and more bureaucracy, aren’t the way to get them.</p><p><blockquote>我想要更多这样的治疗。我想要尽快，而不是每二十年一次。我希望数万亿美元涌入这个行业。我知道更低的回报和更多的官僚主义并不是实现这些目标的方法。</blockquote></p><p> None of this, of course, means blind, passive or foolish naiveté about the drug industry or pricing. Drug manufacturers spend about $160 million a year on lobbying, and people involved in the business donated nearly $30 million a year to politicians running for office. Look through the proxy statements and you’ll see plenty of Big Pharma CEOs living off<i>the fatta the lan</i>(like lots of other CEOs).Yes, of course Medicare should have greater freedom to negotiate drug prices.</p><p><blockquote>当然，所有这些都不意味着对制药行业或定价盲目、被动或愚蠢的天真。药品制造商每年在游说上花费约1.6亿美元，参与该行业的人每年向竞选公职的政治家捐赠近3000万美元。浏览一下委托书，你会发现许多大型制药公司的首席执行官靠<i>法塔局域网</i>（像许多其他首席执行官一样）。是的，医疗保险当然应该有更大的自由来谈判药品价格。</blockquote></p><p> Few people know more about malfeasance and greed in the drug industry than investigative journalist Gerald Posner, who literally wrote the book on it —Pharma: Greed, Lies, and the Poisoning Of America.</p><p><blockquote>很少有人比调查记者杰拉尔德·波斯纳更了解制药业的渎职和贪婪，他写了一本关于制药业的书——制药：贪婪、谎言和美国的中毒。</blockquote></p><p> “Most of the time I agree with your take,” he tells me. “FDA red tape bureaucracy is slow and costly and good R&amp;D can cost a fortune, all with no guarantee of success. So risk takers, i.e. drug companies, should be rewarded with financial incentives.”</p><p><blockquote>“大多数时候我同意你的观点，”他告诉我。“FDA的繁文缛节缓慢且成本高昂，良好的研发可能会花费大量资金，而且无法保证成功。因此，冒险者，即制药公司，应该获得经济激励。”</blockquote></p><p> But, he adds, U.S. drug companies are already getting plenty of help. The U.S. has the longest patent protections of any major economy. He adds that big U.S. pharma companies get huge research support from taxpayers through the National Institute for Health.</p><p><blockquote>但是，他补充说，美国制药公司已经得到了大量帮助。美国是所有主要经济体中专利保护时间最长的国家。他补充说，美国大型制药公司通过美国国立卫生研究院从纳税人那里获得了大量的研究支持。</blockquote></p><p> “From 2010 through 2016, every one of the 210 drugs approved for sale by the FDA were completely or in part funded by the NIH,” he says. The fund came to more than $100 billion, he adds.</p><p><blockquote>“从2010年到2016年，FDA批准销售的210种药物中的每一种都完全或部分由NIH资助，”他说。他补充道，该基金规模超过1000亿美元。</blockquote></p><p> All good points. But I fear that as long as it’s more profitable to invest in cigarettes or booze than it is in curing Alzheimer’s, we will all be left with Plan B for our old age: Hoping and praying we don’t get Alzheimer’s.</p><p><blockquote>都是优点。但我担心，只要投资香烟或酒比治疗阿尔茨海默氏症更有利可图，我们都会为晚年留下B计划：希望并祈祷我们不会得阿尔茨海默氏症。</blockquote></p><p></p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opinion: Only ‘greedy’ drug companies will cure Alzheimer’s<blockquote>观点：只有“贪婪”的制药公司才能治愈阿尔茨海默病</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpinion: Only ‘greedy’ drug companies will cure Alzheimer’s<blockquote>观点：只有“贪婪”的制药公司才能治愈阿尔茨海默病</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">marketwatch</strong><span class=\"h-time small\">2021-06-08 19:59</span>\n</p>\n</h4>\n</header>\n<article>\n<p><img src=\"https://static.tigerbbs.com/783580e857537ceb68ca7c6330ee4132\" tg-width=\"1260\" tg-height=\"736\">Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my fellow members of the (ahem) “mainstream media.”</p><p><blockquote>这里有一个问题要问国会和白宫的每个人，联邦官僚机构，以及我所有的（咳咳）“主流媒体”的同事们。</blockquote></p><p> Now that BiogenBIIB,+38.34%has got approval forits new Alzheimer’s drug—the first approved by the FDA in almost 20 years — how much should they be allowed to charge for it?</p><p><blockquote>既然BiogenBIIB，+38.34%的新药已经获得批准——这是近20年来FDA批准的第一种药物——他们应该被允许收取多少费用？</blockquote></p><p> What’s the ethically correct figure? What will exempt them from charges of “greed” or “gouging?” What is “too much?”</p><p><blockquote>伦理上正确的数字是多少？什么能免除他们“贪婪”或“欺诈”的指控？什么是“太多了？”</blockquote></p><p> The manufacturing cost per pill? The cost plus a small margin? What’s the number?</p><p><blockquote>每粒药丸的制造成本？成本加上一点利润？号码是多少？</blockquote></p><p> I bring this up because few things matter as much for the lives of senior citizens in America—and seniors in the rest of the world—than the development of new drugs. I have personally seen up close how Alzheimer’s destroys people, sometimes as young as their 50s and 60s. This has included close members of my family.</p><p><blockquote>我提出这个问题是因为对于美国老年人——以及世界其他地方的老年人——的生活来说，没有什么比新药的开发更重要的了。我亲眼目睹了老年痴呆症是如何摧毁人的，有时只有五六十岁的人。这包括我的近亲。</blockquote></p><p> Some six million Americans already have this cruel, vicious and incurable disease, and ahorrific 50 million around the world. That’s 50 million death sentences. Ten million more get it every year.</p><p><blockquote>大约600万美国人已经患有这种残酷、恶性和无法治愈的疾病，全世界有5000万人患有这种可怕的疾病。那是五千万个死刑判决。每年还有一千万人得到它。</blockquote></p><p> The drug industry developed five vaccines in one year for COVID-19, a disease associated with the deaths of 3.7 million people world-wide. Alzheimer’s treatments? Oh, one for every 20 years.</p><p><blockquote>制药行业在一年内为COVID-19开发了五种疫苗，这种疾病导致全球370万人死亡。老年痴呆症的治疗？哦，每20年一次。</blockquote></p><p> Let’s be honest: Many people subconsciously shrug off this issue on the principle that Alzheimer’s will only happen to someone else. Alas, many of the people reading this article are going to get this disease. For many more, your father, mother, wife or husband will get it. Or a sibling or close friend. At which point, the “hey, maybe we should have made this a bigger national priority” argument will strike, but too late to help.</p><p><blockquote>老实说：许多人下意识地对这个问题不屑一顾，认为阿尔茨海默氏症只会发生在别人身上。唉，很多读这篇文章的人都会得这种病。对于更多的人，你的父亲、母亲、妻子或丈夫会得到它。或者兄弟姐妹或密友。在这一点上，“嘿，也许我们应该把这作为一个更大的国家优先事项”的论点将会出现，但为时已晚。</blockquote></p><p> This is the context worth bearing in mind when we hear about drugs getting approved—and, just as importantly, when we hear people demagoguing about “greedy” drug companies and “overpriced” drugs. It’s not just this new Alzheimer’s drug, either.</p><p><blockquote>当我们听到药物获得批准时，同样重要的是，当我们听到人们煽动“贪婪”的制药公司和“定价过高”的药物时，这是值得记住的背景。也不仅仅是这种新的老年痴呆症药物。</blockquote></p><p> If “drug” companies are making out like bandits, someone really has to explain to me why it doesn’t show up in the…er…stock prices. In the past decade, investors the iShares U.S. Pharmaceuticals exchange-traded fundIHE,+0.61%have made far lower returns than they could have done just by randomly picking a bunch of non-pharmaceutical stocks out of the newspaper. These companies have been worse investments than a simple S&amp;P 500SPX,-0.08%index fund like the SPDR S&amp;P 500 ETFSPY,-0.10%,or the Invesco S&amp;P 500 Equal Weight ETFRSP,-0.18%.</p><p><blockquote>如果“毒品”公司像强盗一样亲热，有人真的必须向我解释为什么它没有出现在…呃…股票价格中。在过去的十年里，iShares美国制药交易所交易基金的投资者获得的回报远低于仅仅从报纸上随机挑选一堆非制药股票所能获得的回报。这些公司的投资比简单的标准普尔500SPX，-0.08%指数基金（例如SPDR标普500 ETFSPY，-0.10%）或景顺标普500等权重ETFRSP，-0.18%）更糟糕。</blockquote></p><p> Even Biogen itself had substantially underperformed the broader stock market index for a decade. Until Monday.</p><p><blockquote>十年来，甚至百健（Biogen）本身的表现也大幅落后于大盘指数。直到星期一。</blockquote></p><p> No, the industry returns aren’t terrible. But they are hardly the giant free oil well that critics sometimes suggest. I checked out the data from Dartmouth College finance professor Kenneth French, who has tracked stock market returns by industry going back decades. Going all the way back to the 1920s, according to his numbers, the pharmaceuticals industry barely cracks the top one-third of all industries by stock returns. So far this millennium, the total returns from major pharmaceutical companies have been about a third less than those from the S&amp;P 500 index. Biotechs have done much better, but they were a much smaller sector. And even biotech has trailed the returns of alcohol and tobacco companies.</p><p><blockquote>不，行业回报并不可怕。但它们并不是批评者有时所说的巨大的自由油井。我查阅了达特茅斯学院金融学教授肯尼斯·弗伦奇的数据，他几十年前就按行业追踪了股市回报。根据他的数据，追溯到20世纪20年代，制药业的股票回报率勉强跻身所有行业的前三分之一。本世纪迄今为止，大型制药公司的总回报比标普500指数低约三分之一。生物技术做得更好，但它们是一个小得多的行业。甚至生物技术公司的回报率也落后于酒精和烟草公司。</blockquote></p><p> How are we going to get billions of dollars more capital invested in curing Alzheimer’s and diabetes and cancer when investors can make more money investing in making booze and cigarettes? This is upside down.</p><p><blockquote>当投资者可以通过投资制造酒精和香烟赚更多的钱时，我们如何获得数十亿美元的资本投资于治疗阿尔茨海默氏症、糖尿病和癌症？这是颠倒的。</blockquote></p><p> Meanwhile the regulation are all messed up and back to front as well.This headline says it all: “FDA Approves Alzheimer’s Drug Despite Fierce Debate Over&nbsp;Whether&nbsp;It Works.”</p><p><blockquote>与此同时，规则也被颠倒了。这个标题说明了一切：“尽管对阿尔茨海默氏症药物是否有效存在激烈争论，但FDA还是批准了该药物。”</blockquote></p><p> This is nuts. Maybe the new treatment makes things better, maybe it doesn’t. Apparently people aren’t certain. It’s hardly a surprise: The treatment is new, and the disease is complicated. But the first question to ask isn’t whether it makes things better, but whether it makes things worse. The current situation is catastrophic for anyone with the disease. People are dying. Lives are being destroyed.</p><p><blockquote>这太疯狂了。也许新的治疗方法让事情变得更好，也许没有。显然人们不确定。这并不奇怪：治疗方法是新的，疾病也很复杂。但首先要问的问题不是它是否让事情变得更好，而是它是否让事情变得更糟。目前的情况对任何患有这种疾病的人来说都是灾难性的。人们正在死去。生命正在被摧毁。</blockquote></p><p> Waiting to be sure treatment works would be like falling out of a plane with a parachute on, but hesitating to pull the cord because, well, it might not work. It suggests a basic misunderstanding of game theory. (Or common sense.)</p><p><blockquote>等待确定治疗有效就像带着降落伞从飞机上掉下来，但犹豫着要不要拉绳子，因为，嗯，它可能不起作用。这表明了对博弈论的一个基本误解。（或常识。）</blockquote></p><p> It’s one thing to hesitate about approving a new drug for a nonfatal illness. You don’t want to make people sicker, or cause needless suffering or death. But with this kind of illness that really doesn’t apply.</p><p><blockquote>对批准一种治疗非致命疾病的新药犹豫不决是一回事。你不想让人们病得更重，或者造成不必要的痛苦或死亡。但是这种病真的不适用。</blockquote></p><p></p><p> Anyone who says “oh, no, we need to be really careful, and if need be delay these new treatments for years to make sure they are absolutely 100% safe” is speaking from a position of privilege. They should try saying that to someone watching a loved one be destroyed by the illness. It’s easy to play that card when it’s not happening to you, or someone you love.</p><p><blockquote>任何说“哦，不，我们需要非常小心，如果需要，将这些新的治疗方法推迟数年，以确保它们绝对100%安全”的人都是站在特权的立场上说话。他们应该试着对看着亲人被疾病摧毁的人说这句话。当这张牌没有发生在你或你爱的人身上时，很容易打出这张牌。</blockquote></p><p> A look through the Biogen’s public filings tells the sorry story. This new&nbsp;Alzheimer’s&nbsp;treatment entered Phase 3 trials in 2015—six years ago. Did I mention it took one year to get COVID vaccines to market?</p><p><blockquote>浏览一下百健(Biogen)的公开文件就会发现这个令人遗憾的故事。这种新的阿尔茨海默氏症治疗方法于六年前的2015年进入3期试验。我有没有提到COVID疫苗上市花了一年时间？</blockquote></p><p> Meanwhile, check out all the costs associated with developing this treatment. Biogen struck a collaboration deal with Eisai to work on this drug in 2014. Since then the two of them have spent a total of $1.1 billion on it. If it hadn’t been approved, that’s $1.1 billion down the drain.</p><p><blockquote>同时，检查与开发这种疗法相关的所有费用。Biogen于2014年与卫材达成合作协议，开发该药物。从那以后，他们两人总共为此花费了11亿美元。如果没有获得批准，11亿美元将付诸东流。</blockquote></p><p> I want more of these treatments. And I want them quickly, not every two decades. I want trillions pouring into this industry. And I know that lower returns, and more bureaucracy, aren’t the way to get them.</p><p><blockquote>我想要更多这样的治疗。我想要尽快，而不是每二十年一次。我希望数万亿美元涌入这个行业。我知道更低的回报和更多的官僚主义并不是实现这些目标的方法。</blockquote></p><p> None of this, of course, means blind, passive or foolish naiveté about the drug industry or pricing. Drug manufacturers spend about $160 million a year on lobbying, and people involved in the business donated nearly $30 million a year to politicians running for office. Look through the proxy statements and you’ll see plenty of Big Pharma CEOs living off<i>the fatta the lan</i>(like lots of other CEOs).Yes, of course Medicare should have greater freedom to negotiate drug prices.</p><p><blockquote>当然，所有这些都不意味着对制药行业或定价盲目、被动或愚蠢的天真。药品制造商每年在游说上花费约1.6亿美元，参与该行业的人每年向竞选公职的政治家捐赠近3000万美元。浏览一下委托书，你会发现许多大型制药公司的首席执行官靠<i>法塔局域网</i>（像许多其他首席执行官一样）。是的，医疗保险当然应该有更大的自由来谈判药品价格。</blockquote></p><p> Few people know more about malfeasance and greed in the drug industry than investigative journalist Gerald Posner, who literally wrote the book on it —Pharma: Greed, Lies, and the Poisoning Of America.</p><p><blockquote>很少有人比调查记者杰拉尔德·波斯纳更了解制药业的渎职和贪婪，他写了一本关于制药业的书——制药：贪婪、谎言和美国的中毒。</blockquote></p><p> “Most of the time I agree with your take,” he tells me. “FDA red tape bureaucracy is slow and costly and good R&amp;D can cost a fortune, all with no guarantee of success. So risk takers, i.e. drug companies, should be rewarded with financial incentives.”</p><p><blockquote>“大多数时候我同意你的观点，”他告诉我。“FDA的繁文缛节缓慢且成本高昂，良好的研发可能会花费大量资金，而且无法保证成功。因此，冒险者，即制药公司，应该获得经济激励。”</blockquote></p><p> But, he adds, U.S. drug companies are already getting plenty of help. The U.S. has the longest patent protections of any major economy. He adds that big U.S. pharma companies get huge research support from taxpayers through the National Institute for Health.</p><p><blockquote>但是，他补充说，美国制药公司已经得到了大量帮助。美国是所有主要经济体中专利保护时间最长的国家。他补充说，美国大型制药公司通过美国国立卫生研究院从纳税人那里获得了大量的研究支持。</blockquote></p><p> “From 2010 through 2016, every one of the 210 drugs approved for sale by the FDA were completely or in part funded by the NIH,” he says. The fund came to more than $100 billion, he adds.</p><p><blockquote>“从2010年到2016年，FDA批准销售的210种药物中的每一种都完全或部分由NIH资助，”他说。他补充道，该基金规模超过1000亿美元。</blockquote></p><p> All good points. But I fear that as long as it’s more profitable to invest in cigarettes or booze than it is in curing Alzheimer’s, we will all be left with Plan B for our old age: Hoping and praying we don’t get Alzheimer’s.</p><p><blockquote>都是优点。但我担心，只要投资香烟或酒比治疗阿尔茨海默氏症更有利可图，我们都会为晚年留下B计划：希望并祈祷我们不会得阿尔茨海默氏症。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/only-greedy-drug-companies-will-cure-alzheimers-11623152892?mod=newsviewer_click\">marketwatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.marketwatch.com/story/only-greedy-drug-companies-will-cure-alzheimers-11623152892?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1127979401","content_text":"Here’s a question for everyone in Congress and the White House, the federal bureaucracy, and all my fellow members of the (ahem) “mainstream media.”\nNow that BiogenBIIB,+38.34%has got approval forits new Alzheimer’s drug—the first approved by the FDA in almost 20 years — how much should they be allowed to charge for it?\nWhat’s the ethically correct figure? What will exempt them from charges of “greed” or “gouging?” What is “too much?”\nThe manufacturing cost per pill? The cost plus a small margin? What’s the number?\nI bring this up because few things matter as much for the lives of senior citizens in America—and seniors in the rest of the world—than the development of new drugs. I have personally seen up close how Alzheimer’s destroys people, sometimes as young as their 50s and 60s. This has included close members of my family.\nSome six million Americans already have this cruel, vicious and incurable disease, and ahorrific 50 million around the world. That’s 50 million death sentences. Ten million more get it every year.\nThe drug industry developed five vaccines in one year for COVID-19, a disease associated with the deaths of 3.7 million people world-wide. Alzheimer’s treatments? Oh, one for every 20 years.\nLet’s be honest: Many people subconsciously shrug off this issue on the principle that Alzheimer’s will only happen to someone else. Alas, many of the people reading this article are going to get this disease. For many more, your father, mother, wife or husband will get it. Or a sibling or close friend. At which point, the “hey, maybe we should have made this a bigger national priority” argument will strike, but too late to help.\nThis is the context worth bearing in mind when we hear about drugs getting approved—and, just as importantly, when we hear people demagoguing about “greedy” drug companies and “overpriced” drugs. It’s not just this new Alzheimer’s drug, either.\nIf “drug” companies are making out like bandits, someone really has to explain to me why it doesn’t show up in the…er…stock prices. In the past decade, investors the iShares U.S. Pharmaceuticals exchange-traded fundIHE,+0.61%have made far lower returns than they could have done just by randomly picking a bunch of non-pharmaceutical stocks out of the newspaper. These companies have been worse investments than a simple S&P 500SPX,-0.08%index fund like the SPDR S&P 500 ETFSPY,-0.10%,or the Invesco S&P 500 Equal Weight ETFRSP,-0.18%.\nEven Biogen itself had substantially underperformed the broader stock market index for a decade. Until Monday.\nNo, the industry returns aren’t terrible. But they are hardly the giant free oil well that critics sometimes suggest. I checked out the data from Dartmouth College finance professor Kenneth French, who has tracked stock market returns by industry going back decades. Going all the way back to the 1920s, according to his numbers, the pharmaceuticals industry barely cracks the top one-third of all industries by stock returns. So far this millennium, the total returns from major pharmaceutical companies have been about a third less than those from the S&P 500 index. Biotechs have done much better, but they were a much smaller sector. And even biotech has trailed the returns of alcohol and tobacco companies.\nHow are we going to get billions of dollars more capital invested in curing Alzheimer’s and diabetes and cancer when investors can make more money investing in making booze and cigarettes? This is upside down.\nMeanwhile the regulation are all messed up and back to front as well.This headline says it all: “FDA Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works.”\nThis is nuts. Maybe the new treatment makes things better, maybe it doesn’t. Apparently people aren’t certain. It’s hardly a surprise: The treatment is new, and the disease is complicated. But the first question to ask isn’t whether it makes things better, but whether it makes things worse. The current situation is catastrophic for anyone with the disease. People are dying. Lives are being destroyed.\nWaiting to be sure treatment works would be like falling out of a plane with a parachute on, but hesitating to pull the cord because, well, it might not work. It suggests a basic misunderstanding of game theory. (Or common sense.)\nIt’s one thing to hesitate about approving a new drug for a nonfatal illness. You don’t want to make people sicker, or cause needless suffering or death. But with this kind of illness that really doesn’t apply.\nAnyone who says “oh, no, we need to be really careful, and if need be delay these new treatments for years to make sure they are absolutely 100% safe” is speaking from a position of privilege. They should try saying that to someone watching a loved one be destroyed by the illness. It’s easy to play that card when it’s not happening to you, or someone you love.\nA look through the Biogen’s public filings tells the sorry story. This new Alzheimer’s treatment entered Phase 3 trials in 2015—six years ago. Did I mention it took one year to get COVID vaccines to market?\nMeanwhile, check out all the costs associated with developing this treatment. Biogen struck a collaboration deal with Eisai to work on this drug in 2014. Since then the two of them have spent a total of $1.1 billion on it. If it hadn’t been approved, that’s $1.1 billion down the drain.\nI want more of these treatments. And I want them quickly, not every two decades. I want trillions pouring into this industry. And I know that lower returns, and more bureaucracy, aren’t the way to get them.\nNone of this, of course, means blind, passive or foolish naiveté about the drug industry or pricing. Drug manufacturers spend about $160 million a year on lobbying, and people involved in the business donated nearly $30 million a year to politicians running for office. Look through the proxy statements and you’ll see plenty of Big Pharma CEOs living offthe fatta the lan(like lots of other CEOs).Yes, of course Medicare should have greater freedom to negotiate drug prices.\nFew people know more about malfeasance and greed in the drug industry than investigative journalist Gerald Posner, who literally wrote the book on it —Pharma: Greed, Lies, and the Poisoning Of America.\n“Most of the time I agree with your take,” he tells me. “FDA red tape bureaucracy is slow and costly and good R&D can cost a fortune, all with no guarantee of success. So risk takers, i.e. drug companies, should be rewarded with financial incentives.”\nBut, he adds, U.S. drug companies are already getting plenty of help. The U.S. has the longest patent protections of any major economy. He adds that big U.S. pharma companies get huge research support from taxpayers through the National Institute for Health.\n“From 2010 through 2016, every one of the 210 drugs approved for sale by the FDA were completely or in part funded by the NIH,” he says. The fund came to more than $100 billion, he adds.\nAll good points. But I fear that as long as it’s more profitable to invest in cigarettes or booze than it is in curing Alzheimer’s, we will all be left with Plan B for our old age: Hoping and praying we don’t get Alzheimer’s.","news_type":1,"symbols_score_info":{"BIIB":0.9}},"isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114067997,"gmtCreate":1623036925419,"gmtModify":1634095984996,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/114067997","repostId":"1143555139","repostType":4,"isVote":1,"tweetType":1,"viewCount":316,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114065742,"gmtCreate":1623036881786,"gmtModify":1634095985953,"author":{"id":"3582279635767115","authorId":"3582279635767115","name":"xiaoniu2021","avatar":"https://static.tigerbbs.com/2b48490ff89e888e7ae9323ab94ce117","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582279635767115","authorIdStr":"3582279635767115"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/114065742","repostId":"2141926289","repostType":4,"isVote":1,"tweetType":1,"viewCount":557,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}